mklives

SUNPHARMA.. bullish?

ロング
mklives アップデート済   
NSE:SUNPHARMA   SUN PHARMACEUTICAL
SUNPHARMA after a long time, is crossing 200 dma
news about the whistle blower went in favour of the company
can be a contrarion bet in a weak market
above 441 close, can give 10 % returns possibly.
コメント:
sun pharma breaks above 200 dma which is good.. rsi above 60.
buy on dips to 441 and targets of 485 as first target. weekly rsi has double bottomed. looks like 500 can be tested but is a strong resistance since it is 100 weekly dma

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。